LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
29.96
+0.19 (0.64%)
At close: Aug 1, 2025, 4:00 PM
29.66
-0.30 (-1.00%)
After-hours: Aug 1, 2025, 6:32 PM EDT
United States Steel Market Cap
LENZ Therapeutics has a market cap or net worth of $854.52 million as of August 1, 2025. Its market cap has increased by 53.44% in one year.
Market Cap
854.52M
Enterprise Value
646.05M
1-Year Change
53.44%
Ranking
Category
Stock Price
$29.96
Market Cap Chart
Since the IPO on March 22, 2024, LENZ Therapeutics's market cap has increased from $413.64M to $854.52M, an increase of 106.58%. That is a compound annual growth rate of 70.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 854.52M | 7.63% |
| Dec 31, 2024 | 793.95M | 91.94% |
| Mar 22, 2024 | 413.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 685.54B |
| Johnson & Johnson | 403.30B |
| AbbVie | 345.33B |
| AstraZeneca | 232.21B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.51B |
| UnitedHealth Group | 214.33B |
| Novo Nordisk | 211.90B |